Synergy Recognizes September As Pain Awareness Month

Pain Awareness PictureAccording to the U.S. Pain Foundation, 100 million Americans are affected by
chronic pain. Not only is chronic pain the number one reason someone goes to
the doctor, it’s also the leading cause of disability. Individuals who suffer from
this ailment are currently getting overlooked, ignored, or misunderstood,
especially in the wake of the current opioid crisis sweeping our country.

National Study Shows Increased Opioid Abuse

According to a new study, more than one out of three average Americans used a prescription opioid painkiller in 2015, despite growing
concerns that these medicines are promoting widespread addiction and overdose deaths.

Nearly 92 million U.S. adults, or about 38 percent of the population, took a prescribed opioid like OxyContin or Percocet in 2015,
according to results from the National Survey on Drug Use and Health (NSDUH). The National Survey on Drug Use and Health (NSDUH)
is a company that promotes honest responses by allowing participants to log answers into a computer under complete anonymity. 51,200 individuals completed the survey interview for the year 2015.

“The proportion of adults who receive these medications in any year seemed startling to me,” said study co-author Dr. Wilson Compton,
deputy director of the U.S. National Institute on Drug Abuse. “It’s an awful lot of people who take these, mostly for medical purposes, but within that a significant percentage end up misusing them,” he added. The survey defined prescription opioid misuse as people taking the painkillers without a prescription, taking larger doses than prescribed, or using the drugs to get high.

Titanium Dioxide Nanoparticles Can Intensify Inflammatory Reaction

Food products, cosmetics, and some medicines are using an increased amount of Titanium dioxide nanoparticles that could increase inflammation of the digestive system, new research suggests.

Titanium dioxide has historically been considered harmless to the human body however, with increased usage as white pigment (additive E171) in items such as cake icing, marshmallows, toothpastes, and medicine, it has fallen under scrutiny and warned against with some  possible negative effects.

Dr. Gerhard Rogler and researchers from the University of Zurich in Switzerland have studied what happens when the digestive system absorbs nanoparticles of titanium dioxide. A new study published in the journal Gut that individuals with inflammatory bowel disease (IBD) and ulcerative colitis could be at harm due to the digestive system absorbing the nanoparticles of titanium dioxide.

Dr. Rogler concentrated the research on a protein complex inside cells: the NLRP3 inflammasome. This protein complex is part of the non-specific immune system, which detects danger signals and then triggers inflammation. His research team first studied the effect of

Benefits of Home Delivery

When it comes to finding and purchasing medical equipment, you can often find it burdensome due to a variety of issues. For example, 
elderly individuals that rely on supply reorders can often find it difficult to obtain products as they may be unable to drive or are at the
mercy of a caregiver’s schedule. Additionally, individuals located in more rural areas can also find trouble due to a lack of local stores who can provide the supplies they need. This can be especially concerning for individuals with diabetes that require the correct amount of
insulin and supplies each month.

Now Offering Home Medical Equipment (DME)


Synergy Health Services is pleased to announce our new offering of home medical equipment. Synergy’s dedication to individualized care continues by providing patients with the best quality and brand name home medical equipment. This equipment can assist in many areas such as pain relief, diabetes management, and the enhancement of active daily living.

With over 150,000 brand name products, Synergy Health Services is positioned to offer the product that is right for you.

PCAB Accreditation

Synergy proudly announces its achievement of accreditation from the Pharmacy Compounding Accreditation Board (PCAB), thus joining an elite group of pharmacies nationwide with this distinction. Recognition is provided to Synergy for the pharmacy’s commitment to meeting and/or exceeding the highest quality and safety standards in its profession.


Achieving accreditation is a process where healthcare organizations demonstrate compliance with national standards. PCAB accreditation reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.

“We are honored by this accreditation. It confirms our dedication to protecting our patients by practicing safe, high-quality personalized solutions that address patient’s medical needs,” said Michael Palso, Synergy’s COO. “We believe this will only further strengthen the bonds of trust between our pharmacy, patients, and the healthcare providers who rely on us for these specialized medications.”

Established in 2007, PCAB was founded by eight of the nation’s leading pharmacy organizations to create voluntary quality accreditation designation for the compounding industry. The organization promotes, develops, and maintains principles, policies and standards for improving the quality of pharmacy compounding nationwide.

Fighting the Opioid Epidemic

Fighting the Opioid Epidemic

With 78 deaths in the United States each day from opioid overdose and a 300% increase in associated prescription sales since 1999, opiate addiction has reached a crisis level.

In August 2016, the U.S. Surgeon General, Dr. Vivek Murthy, mailed 2.3 million letters to physicians and medical professionals asking for their help to decrease prescription usage of opioids, as he believes that “clinicians have the unique power to end this epidemic.” This campaign, titled “Turn the Tide Rx”, has launched to focus on clinicians in three main areas:

1) Education on the addictiveness of painkillers and how to treat pain safely and effectively;
2) Screening patients for opioid abuse disorder and connecting them with evidence-based treatments;
3) Changing the public view of addiction to be seen as a chronic illness and not a moral issue.


Compounding for pain management offers a unique solution to this opioid epidemic. Clinical research backs up this view as well. In 2013, Patient Outcomes Analytics completed a nationwide survey of 3,600 chronic pain sufferers to assess patients’ experience with topical prescription pain creams in relation to their impact on oral pain medications. Findings published in the Journal of Medical Care, revealed that more than 83 percent of the participants reported a significant decrease in their pain. In addition, a reduction in oral pain medications was reported in 38 percent of these patients.

Prescription topical pain compounds offer advantages over oral opioid medications. These benefits range from a lowered total systemic daily dose for patients to achieve pain relief, site-specific drug delivery, and avoidance of first-pass metabolism. In addition, added benefits include overall decrease in major drug interactions, risk of addiction, and gastrointestinal, renal, or hepatic exposure. These prescription topical pain products work by attacking the pain’s dual pathways directly through the skin at the source of the localized pain.

At Synergy Health Services, we support the U.S. Surgeon General’s goal to curb the overuse of prescription opioids. We honor this pledge as a non-narcotic compounding pharmacy by offering topical pain therapies that are non-addictive and non-abusive.

As an accredited pharmacy, we work directly with physicians and clinicians to offer pain solutions that are customized to meet their patients’ healthcare needs. Despite pain being arthritic, nociceptive, neuropathic, chronic or acute in nature, there are topical therapies available to help reduce patients’ pain level and opioid dosage, as well as the possible weaning of narcotics.

We commend the U.S. Surgeon General’s call to action for the medical community to reduce opioid prescribing practices. Patient-specific, compounded pain medications, from an accredited compounding pharmacy, is what we can offer to support his efforts for alternative treatments. Together, we will take a stand to end this urgent health crisis on opioid dependence to better the community we serve.

Difference In Pill Color May Affect Patient’s Adherence

Hand Full of PillsGeneric medications are biologically identical to their brand-name counterparts, however, their physical traits, like shape or color, usually differ. Patients who take generic drugs that differ in color are 50 percent more likely to stop the intake of the drug, producing possible negative reactions, according to a new study by Brigham and Women’s Hospital (BWH).

The findings were published in the Archives of Internal Medicine. The case-control study analyzed patients taking antiepileptic drugs and looked at the probability that patients who did not refill their prescriptions had been taking medication with a different shape or color from earlier prescriptions.